It improves: Skin glow Texture Mild pigmentation Dullness While it enhances brightness, it does not drastically lighten skin
In terms of bilirubins effects on immune cells, a 2017 study showed (139) that unconjugated bilirubin upregulates CD39 and thus inhibits Th17 immunoreactivity, this promotes several cancers, such as breast, colorectal, and ovarian cancers (140142), and thus, the inhibition of TH17 by unconjugated bilirubin can play a role in inhibiting related cancer effects
Its safety profile is generally favorable, but several specific considerations deserve clinician attention particularly around copper biology, zinc balance, and the small number of patient populations where caution or contraindication applies
Each article connects to one or more related compounds in the AXION catalog